eccogene glp 1 Innovent gets IND for oral GLP-1 agonist Eccogene Announces Positive Topline Results
Description
What current research tells us about cycling GLP-1 medications Here is the honest answer: there are no published clinical trials specifically studying the practice of alternating between semaglutide and tirzepatide
10.2337/dc10-0187 [DOI] [PMC free article] [PubMed] [Google Scholar] 200.Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R, et al
That side effect would soon become the headline
[DOI] [PubMed] [Google Scholar] 11.Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA, et al
41:e4-e5 [PubMed: 29133344] 231
It took years of mounting adverse event reports before Novo Nordisk added adequate warningsand even then, many argue the warnings remain insufficient
